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Alkylresorcinols (ARs) were ﬁrst proposed as potential biomarkers of wholegrain wheat and rye intake a decade ago. Since then
there has been a considerable body of research which suggests that ARs do meet most criteria of a biomarker of these foods. Results
fromhumanstudiesonplasmaARandtheirplasmaandurinarymetabolitesstronglyindicatethatthesecompoundsareresponsive
to whole grain wheat and rye intake and are correlated with various measures of AR consumption. This review brieﬂy summarises
work on the bioactivities of AR and focuses on aspects related to their use as biomarkers of whole grain wheat and rye intake.
Evidence suggests that they thus far broadly fulﬁl the criteria to act as biomarkers of these cereals. However, there are still gaps
in the knowledge on factors relating to the wide interindividual variation, and application to diﬀerent epidemiological cohorts.
Overall, ARs are highly promising biomarkers of whole grain wheat and rye intake and add to our increasing understanding of
whole grains and health.
1.Introduction
Many epidemiological studies link a greater intake of whole-
grain (WG) cereals to a decreased risk of many diet-related
diseases including cardiovascular disease, obesity, type 2
diabetes, and some types of cancer [1–4]. In nutritional
epidemiology, collecting valid dietary intake data, especially
with food frequency questionnaires (FFQs), is challenging
and remains one of the main weaknesses of this type of
research [5]. For estimating WG intake, there are a number
of additional challenges, including the breadth of diﬀerent
foods and processing methods this food category covers,
and the diﬃculty that consumers (and researchers) have in
accurately knowing the WG content of foods consumed [6].
One way of ameliorating this uncertainty around assessment
of WG intake would be to use biomarkers of WG intake in
conjunction with dietary assessment, and perhaps ultimately
without dietary assessment (e.g., in cohorts where dietary
data is not available or of questionable reliability such as
blood banks and the elderly) to provide a nonsubjective
estimate of intake [7]. Biomarkers of WG intake could also
beofuseasmarkersofcompliancein long-termintervention
studies that are being carried out in order to establish
causality between increased WG intake and decreased risk of
disease.
In the early part of this century, alkylresorcinols (ARs)
were proposed as potential biomarkers of wholegrain wheat
and rye intake [8]. ARs are 3,5-dihydroxy-phenolic lipids
with an odd-numbered alkyl chain generally ranging from
C15 to C25, and among food plants, only found in
appreciable quantities in wheat, rye, barley, and triticale (a
wheat × rye hybrid) [9]( Figure 1). The alkyl chains are
mostly saturated (>80%) [9], though unsaturated, keto, and
oxo-derivatives are also found, particularly in rye [10–12].
In the kernels, ARs are only found in the inner pericarp,
hyaline layer, and testa [13], meaning that in food they are
only present in the wholegrain or bran fraction of these
cereals. The ratio of the diﬀerent saturated homologues
diﬀers between the diﬀerent cereals and can be used to
diﬀerentiate between the three main ARs containing cereals
[14]( Figure 2). The ratio of C17:0/C21:0 is approximately
0.1 in wheat (0.01 for durum wheat) and 1 in rye, and this
ratio has been suggested to be a method for determining if
a cereal product contains wheat, rye, or a mixture [14, 15]
(Table 1). Barley has a much larger proportion of C25:0
compared to the other cereals, though overall has much2 J o u r n a lo fN u t r i t i o na n dM e t a b o l i s m
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Figure 1: Basic structure of alkylresorcinols (a), and the two main plasma and urinary metabolites, 3,5-dihydroxybenzoic acid (b), and
3,5-dihydroxyphenylpropianoic acid (c). For the most abundant alkylresorcinols in cereals, R = C17H35–C25H51.
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Figure 2: GC-MS chromatograms of the main AR containing cereals: wheat, rye, and barley. The ratio of the diﬀerent odd-numbered
saturated homologues varies from grain to grain but is generally conserved from variety to variety. The ratio C17:0/C21:0 can be used to
determine if a cereal sample is wheat (∼0.1) or rye (∼1.0) and is reﬂected partially in plasma.
lower total AR concentrations (40–110μg/g versus 300–
1500μg/g for wheat and rye) [9, 16–18]. ARs are not found
in appreciable concentrations in other food plants, though
homologues C15:0, C17:1, and C17:2 have been found in
mangoﬂeshatlowconcentrations(4–17mg/kgfreshweight)
[19]. Estimates for average daily intake range from 12mg in
the United Kingdom to nearly 40mg in Finland [20], though
this may underestimate intakes at the low end of the range
as the small amounts present in white wheat ﬂour were not
accounted for [16].
2. Bioactivityof Alkylresorcinols
Current evidence for an important bioactivity of ARs is
mostly weak and based on in vitro tests, with likely activity
revolving around their ability to integrate into membranes
and inhibit enzymes [21]. A wide variety of bioactivities have
been ascribed to AR from in vitro tests, ranging from induc-
tionofapoptosis,inhibitionoflipoxygenases,andcleavageof
DNA to triglyceride reduction in adipocytes [8, 12, 21, 22].
The range of eﬀective concentrations (based on reported
IC50) is around 3–100μmol/L. Here it is important to note
that the Cmax of plasma alkylresorcinols after a single meal
containing 190mg of rye AR was 3-4μmol/L [23], meaning
thatlikelyplasmaconcentrationsareunlikelytoreachapoint
where acute eﬀects could be observed at “normal” intakes
of 12–40mg/d. The maximum AR concentration found in
a small sample of human adipose tissues was 3.8μmol/kg
[24], suggesting that AR could possibly accumulate in
some tissues to relatively high concentrations and play
some biological role, though signiﬁcant in vitro eﬀects on
lipolysis in adipocytes were only observed at 34–38μmol/L
[22].
ARs do have some antioxidant capacity, but this is
weak compared to known antioxidants such as α-tocopherol
[25, 26]. They were found to have slight antimutagenic
and better antioxidant eﬀects in membrane-based models
[26]. The concentration needed to observe the inhibitionJ o u r n a lo fN u t r i t i o na n dM e t a b o l i s m 3
Table 1: Key steps for validating a biomarker, and if alkylresorcinols meet these criteria as biomarkers of alkylresorcinol containing foods
(adapted from [75, 82]).
(1) Present in wholegrain foods, but not reﬁned foods, nor other food sources
Quantitative analytical methods
for grains and food
GC [9, 83]
HPLC [16, 84, 85]
Colorimetry [86–88]
Not present in other foods In food plants, only found in wheat, rye and barley, and genetically related crops,
and in low amounts in mango ﬂesh. Very low amounts in beer and animal fat. [9, 19, 70]
Not aﬀected by food processing AR stable during baking and pasta production [9, 15]
Limited eﬀect of fermentation and germination in rye [89, 90]
V a r i a t i o ni nr a wm a t e r i a l
Wheat (350–900μg/g) [9, 15, 91, 92]
Rye (500–1300μg/g) [83, 93, 94]
Barley (30–100μg/g) [17, 18]
(2) Intake, absorption, distribution, metabolism, and elimination
Quantitative analytical methods
for biological samples
GC-MS (plasma, erythrocytes, adipose tissue, urinary metabolites) [41, 55, 57]
[46, 59]
GC-MS/MS (plasma, erythrocytes) [58]
LC-MS/MS (plasma) [56]
HPLC-CAED (metabolites) [48, 49]
Intake Average intake in the UK and Sweden estimated to be 12 and 23mg/d, respectively [20]
Absorption Pigs: 60–79% depending on dose [44]
Humans: 58% ileal absorption [43]
Distribution Rats: negligible accumulation 100h after a single dose [44]
Adipose: AR-measured in rat and human adipose [29, 46]
Metabolism
Main AR metabolites in humans: DHBA and DHPPA [47]
DHBA and DHPPA also measured in human plasma [49]
DHPPA extensively glucuronidated in human urine [59]
Elimination 61% and 31% of a single dose eliminated in faeces and urine in rats [44]
Urinary recovery 45–89% depending on dose [45]
(3) Dose response and pharmacokinetics
Dose response Increased dose of AR leads to decreased absorption in pigs [44]
Urinary recovery % lower with increased AR dose [45]
Pharmacokinetics
Pigs: Tmax:3h ;T1/2:4h [ 50]
Humans: Tmax1:2 . 8h ;Tmax2:6 . 7h ;T1/2:4 . 8h [ 23]
Plasma metabolites: Tmax:6h ;T1/2: 10–16h
Urinary metabolites: Tmax:6h ;T1/2: 10–12h [52, 53]
(4) Determinants of biological concentrations, variation, and reproducibility
Determinants of plasma
alkylresorcinol concentration
Gender: males have generally higher concentrations [62, 63]
Triglycerides and lipoproteins [27, 63]
Nonesteriﬁed fatty acids [63]
V a r i a t i o ni nd i ﬀerent
populations
Healthy subjects, fasting plasma
Mixed results for females with hormone-related cancers [37, 70]
Reproducibility and validity Intervention studies: good-to-moderate ICC [54, 63]
Free-living studies: low ICC [62]
(5) Application in clinical and epidemiological studies
Surrogate endpoint for WG
intake Endometrial cancer case-control study: no diﬀerence in nonfasting plasma AR [38]
Validation of dietary assessment
tools WG FFQ: correlation with FFQ: 0.53 [76]
Biomarker of compliance to an
intervention WG interventions [51, 63, 74]4 J o u r n a lo fN u t r i t i o na n dM e t a b o l i s m
of LDL oxidation was 2.5μmol/L and 75μmol/L to observe
antimutagenic eﬀects [26], whereas the average AR concen-
tration in erythrocytes after an AR-rich diet was 315nmol/L
packed cells, and 166nmol/L plasma in total lipoproteins
[27], suggesting that strongly bioactive concentrations are
unlikely in blood under normal conditions.
O n l yl i m i t e di nv i v ow o r kh a sb e e nc a r r i e do u to n
the possible biological function of AR, with one study
demonstrating that, at up to 5g/kg feed, there is no
toxic eﬀect [28], and another demonstrated that AR could
increase tissue γ-tocopherol concentrations via competitive
inhibition of its metabolism by CYP450 enzymes [29]. Oral
dosing with pure AR has not been tested in humans. While
most evidence does not point to a strong bioactivity of
AR, there is an increasing amount of in vitro and animal
work that suggests that AR may play a role in preventing
intestinal cancers. Recent studies suggest that AR are one
of the main active components in the prevention of colon
cancer by wheat bran and wheat bran oil in mouse and
in vitro models [30–32], which is supported by previous
evidencesuggestingthatcerealARshavesomeantimutagenic
and apoptotic activity [33–35], implying a mechanism for
colon cancer prevention beyond ﬁbre. This may not be the
case for all types/stages of cancer, and puriﬁed AR had no
eﬀect on implanted prostate cancers in mice although rye
bran did inhibit tumour growth in the same model [36].
As m a l lc a s e - c o n t r o ls t u d yw i t hs u b j e c t sw i t hb r e a s tc a n c e r
found that plasma and urinary AR metabolites were lower
in patients with breast cancer though cereal ﬁbre intake
was also lower, and it is not possible to imply causality
[37]. In a larger case-control study, plasma AR did not
predict lower endometrial cancer risk in Danish women [38]
though, for both types of hormone-related cancers, there
is no strong link between incidence and consumption of
wholegrains.
3. AlkylresorcinolsasMarkersof
WholegrainCerealsinFood
ARs have been suggested to be potential markers for WG
wheat and rye in food products [14]a n dh a v eb e e nu s e d
in multianalyte methods for determining the presence of
diﬀerence cereal fractions in cereal foods, with AR being
most indicative of the inner pericarp and testa [39, 40]. AR
could also be used as a method for checking contamination
of nongluten containing cereals with gluten containing
cereals (wheat, rye, and barley). Even white ﬂour contains
low amounts of AR (20–50μg/g; [16]), meaning that suf-
ﬁciently sensitive methods (e.g., gas chromatography-mass
spectrometry (GC-MS) or high-performance liquid chro-
matography coupled to either CoulArray electrochemical
detection (HPLC-CAED) or ﬂuorescence detection) could
be suitable for this purpose. Similarly, plasma AR could be
used as a method to check for the compliance of people with
coeliac disease to coeliac-free diets, as even people following
WG-free diets have low plasma AR concentrations, while
people avoiding all gluten containing cereals have no AR
present in their plasma [41].
4. Alkylresorcinolsas Biomarkersof
Wholegrain Wheat and Rye Intake
The general criteria for an intake biomarker and how well
AR meet these are outlined in Table 1. As saturated ARs
are only found in the outer parts of WG wheatrye, barley,
and triticale, and not in other food plants, they are good
potential biomarkers of these cereals (they can also be
markers for the bran intake, though generally bran alone
is consumed in much lower quantities than the wholegrain
and is not included in the American Association of Cereal
Chemist’s wholegrain deﬁnition [42]). In addition, ARs are
not destroyed during food processing [9, 15]a n da r ew e l l
absorbedinhumans[43]thoughdatafrompigsandhumans
suggests that the percentage absorption is lower at higher
doses [44, 45]. After absorption, ARs are transported in
lipoproteins (mostly HDL) [27] and may be distributed and
stored in some tissues, especially adipose tissue [29, 46]. ARs
are metabolised via β-oxidation of the alkyl chain into two
main metabolites: DHPPA and DHBA [47]. These metabo-
lites can be measured in plasma and urine and are also being
assessed as biomarkers of wholegrain intake [48, 49].
Kinetic considerations are important in assessing if a
biomarker could be a short, medium, or long-term indicator
of dietary exposure. The half-life of AR in plasma is around
5h [23] though the exact shape of the curve may diﬀer
against a background of regular AR intake compared to a
single dose after a washout [50, 51]. For the two main AR
metabolites, the estimated half-life is 10–16h in plasma [52]
and 10–12h in urine [53] though the dose used (100mg
total AR) is far greater than what would be expected for
even a single day consuming WG-rich foods [20]. Landberg
et al. [45] found in a dose-response study that increasing
doses of AR lead to lower recoveries of AR metabolites in
urine (89–45% between 22.5 and 90mg AR/d), agreeing
with previous data from pigs [44] that an increased intake
does impact on absorption and metabolism, and that AR
response in biological ﬂuids may not be linear, especially
at higher intakes (Figure 3). Fasting ARs do increase with
regular intake, but also rapidly decrease with decreased or
no intake (e.g., [27, 51, 54]; Figure 4), so that irregular intake
of WG food would potentially be an important confounding
factor though as cereal-based foods are generally part of the
staple diet, their intake tends to be regular. One possibility
for the use of AR as long-term biomarkers of WG intake is
their analysis in adipose tissue [46]. While it is not known
how important this pool is, nor the factors governing its
turnover, it could be of use in studies where adipose tissue
biopsy samples are available.
4.1. Methodological Considerations. A R sh a v eb e e nq u a n t i -
ﬁed in biological samples using a variety of methods. In
plasma, they have been analysed using GC-MS [41, 55]
andliquidchromatography-tandemmassspectrometry(LC-
MS/MS) [56], erythrocytes using GC-MS [57]a n dG C -
MS/MS [58], and in adipose tissue using GC-MS [24]. The
two AR metabolites have been analysed in urine using GC-
MS [47, 59] and in both plasma and urine using HPLC-
CAED [48, 49]. In urine, the HPLC-CAED and GC-MSJ o u r n a lo fN u t r i t i o na n dM e t a b o l i s m 5
y = 2.7228x + 49.038
R2 = 0.8033
0
100
200
300
400
500
600
700
0 20 40 60 80 100 120 140 160
P
l
a
s
m
a
 
t
o
t
a
l
 
a
l
k
y
l
r
e
s
o
r
c
i
n
o
l
s
 
(
n
m
o
l
/
L
)
Alkylresorcinol intake (mg/d)
(a)
P
l
a
s
m
a
 
t
o
t
a
l
 
a
l
k
y
l
r
e
s
o
r
c
i
n
o
l
s
 
(
n
m
o
l
/
L
)
Alkylresorcinol intake (mg/d)
y = 5.6815x +
R2 =
0
50
100
150
200
250
300
350
400
0 5 10 15 20 25 30
23.04
0.7863
(b)
Figure 3: Relationship between mean AR intake and the mean of plasma AR across published studies (a). Where direct AR intake data was
not provided, it was estimated from literature values if possible. Values are arithmetic means, and error bars are the standard deviation.
Figure (b) uses data from studies where there has been an arm/group with an AR intake equivalent to 0–48g of WG wheat (0–27mg AR/d)
to give an idea of the range at “normal” intakes, as well as the likely intercept for no WG intake.
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Figure 4: An example of interindividual variation of plasma
alkylresorcinols under controlled conditions. The wholegrain inter-
vention delivered approximately 62mg alkylresorcinols/d. Each
time point is one week apart. Data are from [51].
give comparable results [60]. Due to the relatively low
concentrations present in plasma, MS-based methods are
needed for the intact AR. GC-MS has been the main instru-
ment used though this requires liquid-liquid extraction
followedbysolidphaseextractioncleanupandderivitasation
comparedtoonlyliquid-liquidextractionandcentrifugation
for normal-phase LC-MS/MS. For both methods, run times
are similar (15–20 minutes injection to injection) though
GC-MS has marginally greater sensitivity. MS also has the
advantage that labelled internal standards can be used that
are less prone to contamination or peak-overlapping issues
than other types of internal standard. The use of the cheaper
HPLC-CAED for analysis of metabolites for large cohorts of
samplesisattractivebutneedstobebalancedagainstalonger
sample preparation as samples need to be deconjugated
overnight, and liquid-liquid extraction is still required for
plasma samples. A longer chromatographic separation and
reequilibration time is needed (60 minutes per sample),
greatly reducing throughput, and there is the potential for
overlapping peaks; paracetamol/acetaminophen has been
found to coelute with DHBA [61]. Additionally there is no
informationonifwheatorryewasthemainsourceofwhole-
grain, if this is of interest. Ultimately antibody-based assays
or similar methods will be required for AR/AR metabolite
analysis to be routine in large epidemiological cohorts.
4.2. Studies Using AR as a Biomarker
4.2.1. Intervention Studies. ARs have now been measured
in a number of intervention studies which now allows an
overview of their performance under a variety of conditions.
All studies have found that plasma AR and AR metabolites in
plasma and urine are generally responsive to increased WG
wheat/rye intake and that concentrations decrease rapidly
on WG-free diets. The published studies are summarised
in Figures 4 and 5,a n dT a b l e s2 and 3. While on average
plasma ARs are highly responsive to the consumption of
foods containing AR, there is a wide range of interindividual
variation. Landberg et al. [54] found that repeatability, as
determined using the intraclass correlation coeﬃcient, was
good under intervention conditions (ICC = 0.88 – 0.9),
but less so under free-living conditions (ICC = 0.42–0.48,
with one study ﬁnding a large diﬀerence between men and
women) [62–64]. This variation in free-living subjects does
make it diﬃcult to classify an individual’s WG wheat/rye
intake with great precision based on a single sample though
currently it appears as though it is a valid measure for
comparing diﬀerent populations, as mean plasma ARs are
well correlated with mean AR intake when results from
relevant studies are combined (Figure 3).
4.2.2. Correlation of AR in Biological Fluids with Measure-
ments of Wholegrain Intake. Correlations between plasma
AR and various measures of their intake (AR intake, WG
intake, cereal ﬁbre intake) range between 0.25 and 0.586 J o u r n a lo fN u t r i t i o na n dM e t a b o l i s m
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Figure 5: Relationship between mean AR intake and the mean of
urinary AR from three published studies. Where direct AR intake
data was not provided, it was estimated from literature values
if possible. Values are arithmetic means, and error bars are the
standard deviation.
(Table 2), with generally better correlations with more
detailed dietary intake instruments. The studies using a
general diet FFQ had the lowest correlations (<0.4), with
food diaries between 0.32 and 0.52, and weighed food
records and speciﬁc WG FFQ between 0.5 and 0.58. This
ﬁts with the assumption that general dietary recording
methods such as FFQ are not the best instruments for
collecting data on WG intake. The correlations found for
plasma and urinary AR metabolites are in a similar range
to the intact compounds (Table 3). While measuring urinary
metabolites has an advantage over plasma samples as they
are relatively unaﬀected by ﬂuctuations due to diﬀerent
meal times (provided they are 12 or 24h collections [65],
presently there does not appear to be an advantage for either
AR or their metabolites, and the metabolites are yet to be
assessed in larger populations (>100 subjects) and at lower
levels of AR intake (Figure 5). In the one study where the
two have been compared, there were no major diﬀerences
between total plasma AR or urinary AR metabolites [66].
The type of dietary exposure measurement related to AR/AR
metabolite response surprisingly does not appear to be of
great importance, as even very broad categories such as WG
intake or rye intake lead to similar correlations to AR intake.
One exception is in an intervention study based in the UK,
w h e r em a n ys u b j e c t sh a dl o wW Gi n t a k e ,b u ts t i l lv a r i e di n
AR intake due to a high consumption of reﬁned wheat foods,
and correlation with AR intake was somewhat better than
with WG intake (Table 2)[ 63].
Correlations for AR and AR metabolites are generally
higher than those for α-carotene, β-cryptoxanthin, and
lycopene for consumption of vegetables, fruits, and toma-
toes, respectively [67, 68], and as in the case of fruits and
vegetables, the choice of dietary recall method is important.
Correlations could be improved by the use of absorption
estimates to improve the association with estimated intake
and plasma AR. Absorption estimates improved validity
coeﬃcientsforserumlycopenedeterminedusingthemethod
oftriadsby50%and100%forlycopeneintakedeterminedby
3DWFR [69]. Limited human absorption and bioavailability
dataexistforAR[23,43,45],andthesestudieshavegenerally
used intakes well beyond what would be expected in the
general population, and more studies of this nature will be
invaluable for improving the estimation of WG intake via
plasma AR.
4.2.3. Application of Alkylresorcinols as Surrogate Measure-
ments of WG Intake in Epidemiological Studies. To date, only
o n es t u d yh a su s e dA Ra sas u r r o g a t em a r k e ro fW Gi n t a k e .
This study did not ﬁnd a relationship between plasma AR
and endometrial cancer incidence [38] but did ﬁnd that
nonfasting plasma AR and rye bread intake were moderately
correlated (r = 0.25) [70]. This study speciﬁcally used plasma
AR measurements in an attempt to improve the estimation
of WG intake in this cohort. As this study used nonfasting
plasma samples, there may have been greater variation,
making it potentially more diﬃcult to ﬁnd associations, even
when time since last meal is accounted for. The half life
of AR is relatively short [23], and a single consumption
event is unlikely to have a major impact on overnight fasting
plasma AR concentrations but could do on a nonfasting
sample. Andersson et al. found that the use of nonfasting
samples leads to poor reproducibility (ICC = 0.18) [64],
suggesting that they may not be ideal samples for using AR
as biomarkers of WG intake. In this respect, more work is
needed to compare the validity of fasting versus nonfasting
plasma samples.
4.2.4. Alkylresorcinols as Biomarkers of Compliance. Dietary
complianceisoftenuncertainindietaryinterventionstudies;
particularly,free-livingstudies runoverlongperiods oftime.
Compliance biomarkers are sometimes used in nutrition
interventionstudiestosupportdietrecordcollection,though
often these biomarkers are directly related to health out-
comes or nutrient status, for example, plasma carotenoids,
lipids, and 24h urinary nitrogen and potassium [71–73].
Compliance biomarkers not only provide an additional
control of dietary compliance but can be an additional
motivating factor for subjects to comply, if they know that
this will be checked in their biological samples.
Plasma ARs have only been used as a compliance bio-
marker in a few studies to date [51, 74]. One reason for
this is that there is still uncertainty around cut-oﬀ points
for determining when a person has not been eating a
certain quantity of WG per day, or if they are naturally low
absorbers/fast metabolisers of AR. Without clear criteria for
determining compliance, it is diﬃcult to exclude subjects on
the basis of AR measurements, if traditional measurements
indicate that they are compliant. At the population level, it
appears as though it is not diﬃcult to distinguish between
0-1 servings of WG versus 3 servings of WG (e.g., Figure 3)
using plasma AR; at anindividual level, it is questionable due
to the great amount of interindividual variation. Table 4 lists
the means and where possible the ranges for total plasma AR
for nonwholegrain or low WG diets in the literature to date.
Mean concentrations range from 33 to 84nmol/L though,J o u r n a lo fN u t r i t i o na n dM e t a b o l i s m 7
Table 2: Correlations of plasma alkylresorcinol concentration with diﬀerent measurements of wholegrain intake from previously published
studies.
N Gender Country Type of study Dietary assessment
method
Dietary exposure
parameter Correlation P value C17:0/C21:0 Reference
39 Fa Finland Intervention 4DFRb Rye bread intake 0.34 0.037 0.84 [95]
39 F Finland Intervention 4DFR Insoluble ﬁbre 0.39 0.013 0.84 [95]
28 F+M Sweden Intervention 3DFRc AR 0.58 <0.001 0.30 [77]
56 F Finland Free-living 5DFRd Cereal ﬁbre 0.38 0.004 0.62 [66]
29 F+M Switzerland Free-living 3DWFRe WG intake 0.57 <0.001 0.17 [76]
29 F+M Switzerland Free-living WG FFQf WG intake 0.55 <0.001 0.17 [76]
360 F Denmark Prospective FFQg Rye bread intake 0.25 <0.001 0.40 [70]
266 F+M UK Intervention FFQ WG intake 0.35i <0.001 0.07 [63]
266 F+M UK Intervention FFQ WWh intake 0.43i <0.001 0.07 [63]
266 F+M UK Intervention FFQ AR intake 0.39i <0.001 0.07 [63]
aF: female, M: male
b4DFR: 4-day food record
c3DFR: 3-day food record
d5DFR: 5-day food record
e3DWFD: 3-day weighed food diary
fWG-FFQ: Wholegrain food frequency questionnaire
gGeneral diet food frequency questionnaire
hWW: Wholegrain wheat
iAfter 16-week intervention.
Table 3: Correlations of plasma and urinary alkylresorcinol metabolites (DHBA and DHPPA) with diﬀerent measurements of wholegrain
intake from previously published studies.
N Gender Country Type of study Dietary assessment
method
Diet exposure
parameter
AR
metabolite Plasma/urine Correlation P value Reference
56 Fa Finland Free-living 5DFRb Cereal ﬁbre DHBAc 24h urine 0.37 0.005 [66]
56 F Finland Free-living 5DFR Cereal ﬁbre DHPPAd 24h urine 0.41 0.002 [66]
56 F Finland Free-living 5DFR Cereal ﬁbre DHBA Plasma 0.41 <0.01 [96]
56 F Finland Free-living 5DFR Cereal ﬁbre DHPPA Plasma 0.46 <0.01 [96]
56 F Finland Free-living 5DFR Cereal ﬁbre Total AR
metabolites Plasma 0.42 <0.01 [96]
60 F Finland Free-living 5DFR Rye DHBA Plasma 0.32 <0.05 [97]
60 F Finland Free-living 5DFR Rye DHPPA Plasma 0.39 <0.01 [97]
60 F Finland Free-living 5DFR Rye Total AR
metabolites Plasma 0.33 <0.05 [97]
60 F Finland Free-living 5DFR Rye DHBA 24h urine 0.52 <0.001 [97]
60 F Finland Free-living 5DFR Rye DHPPA 24h urine 0.44 <0.001 [97]
60 F Finland Free-living 5DFR Rye Total AR
metabolites 24h urine 0.48 <0.001 [97]
aF: female
b5DFR: 5-day food record
cDHBA: 3,5-dihydroxybenzoic acid
dDHPPA: 3,5-dihydroxyphenylpropionoic acid.
when reported, the median is often much lower than the
arithmetic mean, indicating that often the mean is skewed by
relativelyfewhighconcentrations,resultinginhigh-standard
deviations. Assessing the studies with the greatest dietary
control (subjects instructed to avoid other cereal foods),
as well as the skewness of the data (median versus mean)
and the standard deviation, it would appear that someone
with a plasma AR concentration >100nmol/L is probably
eating at least some WG in their diet, and, conversely, if a
subject has a plasma AR concentration of <60–70nmol/L,
then they are probably not eating any WG in the diet. By
plotting the studies that have recorded low intakes of AR
(<30mg/d), a diet free of cereal AR would lead to a mean
plasma AR concentration of 31nmol/L (Figure 3(b)). There
is a great need for controlled studies which will allow the
determination of realistic ranges for people eating no or less8 J o u r n a lo fN u t r i t i o na n dM e t a b o l i s m
Table 4: Plasma AR concentrations when subjects have consumed low or essentially AR-free diets.
N Gender Country AR intake
(mg/d) Intervention type
Duration of
intervention period
(weeks)
Median Mean SD Range Reference
39 Fa FI 5.34b Replace all bread with
intervention breads 8 36.6 26.2 10.9–55.8c [95]
15 F+M FI 3b Replace all bread with
intervention breads 1 25–30 12–41 5.5–171 [27]
28 F+M SE 6.8 All cereal foods provided 6 59 57 9–220 [77]
17 M SE 8.2 Replace all cereal foods 6 33 72 101 17–410 [54]
17 F+M CH 5 Fully controlled diet 2 40 44 17 27–89 [51]
34 F DK 3.1d Replace part of cereals in
diet 12 61 78 43.7 16–246 [74]
266 F+M UK 17 WG consumption < 30g/d 0 69.5 84.3 136 10–875 [63]
16 F+M SE WG-free
diet Avoid all WG foods 1 60–68 33–37 23–178 [45]
17 F+M CH WG-free
diet Avoid all WG foods 1 19–32 25–38 13–21 7–82 [51]
aF: female, M: male
bEstimated intake from reﬁned wheat bread intake
cExcludes outliers
dAmount provided by intervention, not total diet.
than one serving of wholegrain per day, and to determine at
what amount of wholegrain intake is it possible to say that
they are categorically complying with the diet.
4.2.5. Response of AR and AR Metabolites in Biological Fluids
after Interventions. Using eﬀect size estimates, it is possible
to estimate the average response of plasma AR to a given
amount of AR or WG intake. Landberg et al. [70]e s t i m a t e d
that plasma AR would increase on average by 85nmol/L
for every 100g of rye bread eaten in a Danish population,
equating to an increase of 85nmol/L for every 70mg of
AR consumed (based on 700μg AR/g for Danish rye bread
[9, 16]). In a UK intervention study, it was estimated that
10g of WG would lead to a 6% increase in plasma AR [63].
4.2.6.UseoftheAlkylresorcinolHomologueRatiosinBiological
Samples. The ratio of the homologues C17:0 and C21:0
is indicative of wheat or rye in cereal samples, and this
has been found to be reﬂected to some extent in human
samples [27] although the ratio after a rye diet is a lot less
than 1—usually around 0.3. This is presumed to be due
to the faster metabolism of the longer chain AR [23]. In
populations where both wheat and rye are eaten, it could
be possible to use the C17:0/C21:0 ratio to determine if
a person eats more of one of these cereals than the other.
Presently there has been little speciﬁc research on the use of
this ratio to determine the source of the cereal in the diet
t h o u g hi ti sc l e a r l yd i ﬀerent between wheat-based and rye-
based interventions. As the ratio in wheat is never above
0.1, it would theoretically be impossible for a subject just
eating wheat to have a ratio above 0.1, so that any ratio above
this in plasma would indicate at least some rye in the diet.
However, this can be confounded at low concentration levels
as C17:0, a minor homologue in wheat, may be close to the
limit of quantiﬁcation in plasma. In studies in populations
thathaveryeasanimportantsourceofwholegrain,whereAR
concentrations have been measured (i.e., Denmark, Finland
and Sweden), the ratio is generally above 0.1 [75]. However,
in those populations where rye is not commonly consumed,
the ratios are generally lower: 0.17 ± 0.14 for Switzerland
[76], 0.06 after a 16-week WG-based intervention in the UK
[63], and 0.08 ± 0.06 after a 12-week WG wheat intervention
in Danish women [74]( Table 2). Together these results
suggest that the C17:0/C21:0 ratio should be indicative
of the source of AR beyond intervention studies and that
ratios above 0.15 are probably indicative of rye intake,
provided that potential analytical errors are accounted for.
More understanding of the absorption and metabolism of
the diﬀerent homologues is required for more accurate use
of the C17:0/C21:0 ratio for determining the source of AR.
4.2.7. Noncereal Determinants of Plasma Alkylresorcinol
Concentration. While the wide interindividual variation of
plasma AR concentrations with similar intakes is well
established (e.g., [51, 77]), there is still little information
about what additional factors inﬂuence AR concentrations
in plasma, and their metabolism. Two studies have found
diﬀerences in concentrations between males and females
[62, 63], but no such consistent eﬀects have been found for
ageorBMI[62,63,70].Underinterventionconditions,while
mean AR concentrations were diﬀerent between the genders,
theabilityofARtodistinguishbetweendiﬀerentintakelevels
was similar [63], but ICC estimated for free-living Germans
was very diﬀerent, with females having much higher ICC for
repeated plasma AR measurements than males [62]. Plasma
lipids are correlated with plasma AR, though whether this
is an independent determinant is debatable, as two studies
have found that adjusting for total plasma lipids has hadJ o u r n a lo fN u t r i t i o na n dM e t a b o l i s m 9
little or no eﬀect on correlations with measures of AR intake
[63,70].AsARsdonotappeartoplayaparticularroleinvital
bodily functions, it is unlikely that there are speciﬁc control
mechanisms that would exert homeostatic control over AR
concentrations in plasma or excretion in urine.
4.2.8. Application of Biological Measurements of Alkylresor-
cinols for Dietary Recall Method Validation. While in some
cases measurements of AR or AR metabolites could be used
where dietary intake data does not exist or is not well suited
for determining WG intake, the true potential of measuring
AR in epidemiological studies lies in improving estimations
of WG intake. Examples of this are the calibration of dietary
recall methods, and to identify likely under- or overreporters
of intake [78] .T h em e t h o do ft r i a d si saw i d e l yu s e dt o o lt o
calibrate new dietary questionnaires, using a “gold standard”
method (e.g., weighed food record or 24h recall), the
questionnaire being tested, and a biomarker [79]. Because
the measurement errors for the two subjective methods are
correlated, the biomarker provides a crucial unbiased mea-
surement of intake [80]. In a small study (n = 29) [76], the
validity coeﬃcients (a measure of “closeness” to estimated
true intake) was 0.65 for plasma AR (Ross et al. unpublished
observations),thoughlargernumbersofsubjects(e.g.,>100)
would be needed to strengthen this observation. Estimation
of how well AR or AR metabolite measurements classify or
rank subjects according to intake is also important to gauge
their validity as biomarkers of intake [81] to know if they can
reliably distinguish between extremes of WG intake.
5. Notes for Using Alkylresorcinols in
ClinicalTrials
Researchers wishing to use AR as biomarkers of WG intake,
either as a surrogate marker of intake, or as a check of com-
pliance should bear in mind the following.
(i) Blood is best collected on EDTA—while no studies
have directly compared EDTA versus other coagu-
lants, generally EDTA provides better stability for
lipophilic compounds.
(ii) Ifpossible,collectcerealfoodsamplesassociatedwith
the study (if an intervention) or from the area where
the study has been carried out, in order to get an
estimate of AR intake. Some foods may diﬀer from
what might be expected.
(iii) If possible, keep some check on the time since last
meal. Nonfasting samples are not recommended for
estimating possible WG intake, and large diﬀerences
in time since last meal between subjects or time
points may have an impact on the results.
(iv) ARs are relatively responsive to changes in WG
wheat/rye intake, and a one-week non-WG washout
is suﬃcient to go from high plasma AR concentra-
tions to low plasma AR concentrations.
6. CurrentStatusandGaps
Presently, ARs appear to be highly promising biomarkers of
wholegrain wheat and rye though there are many factors that
are poorly understood. Present studies ﬁnd that intake of
these grains still only accounts for 9–11% of the variation
observed, even under relatively controlled conditions. This
would suggest that unknown genetic or lifestyle factors play
an even larger role in determining their concentration in
individuals, even if the only dietary source is from these
cereals. However, there is a strong correlation between mean
concentrations and mean intake, suggesting that while ARs
may be only moderate in predicting individual WG intake,
they may strongly predict mean intake in larger populations.
Now that it is clear that plasma AR increases with greater
WG intake, there is a need for more studies that look at
the validity of AR as biomarkers at ranges of WG intake
that are relevant to the intake that would be expected in
general populations. More studies are also needed in non-
European populations in order to assess their applicability
across diﬀerent types of WG intake.
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